ReviewJournal of pharmaceutical sciences2022

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment.

Gokben Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.